Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP412235.RAeNeynT_tcqqiYFYX_9C3JrIxAnhYdK3E64CTAXdGWBY130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412235.RAeNeynT_tcqqiYFYX_9C3JrIxAnhYdK3E64CTAXdGWBY130_provenance.
• NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
• NP624353.RAT5QYn6iDQfhWQJOG-wiE9HjeQoUpVJOz0wYt1zq_KFM130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624353.RAT5QYn6iDQfhWQJOG-wiE9HjeQoUpVJOz0wYt1zq_KFM130_provenance.
• NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_provenance.
• NP1233085.RAaciWn4I6dqX7u_7AOlhqDd4om1HIg_jTQ2H8S0ysoRg130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233085.RAaciWn4I6dqX7u_7AOlhqDd4om1HIg_jTQ2H8S0ysoRg130_provenance.
• NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233088.RAaZdY-btX_6PDSmK-7Ayrmr4zHPYnfTodnw2IA9C51hk130_provenance.
• NP1233091.RAb3G96MFJBiQkpfrjAFz81f4RSeBf1ALMvsJpNpmwQw0130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233091.RAb3G96MFJBiQkpfrjAFz81f4RSeBf1ALMvsJpNpmwQw0130_provenance.
• NP411712.RACloNlv_1E9yJ6lRVNZRcSdLRzXzRqJlQeO0pzTEQpi8130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411712.RACloNlv_1E9yJ6lRVNZRcSdLRzXzRqJlQeO0pzTEQpi8130_provenance.
• NP1233090.RApIh60odkWyv_J6jM9PEDHNjlxuiccsq82F_szPxaORI130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233090.RApIh60odkWyv_J6jM9PEDHNjlxuiccsq82F_szPxaORI130_provenance.
• NP623511.RALgDG1eFc9iwZGX08fEgmy8tB8sC670TAhJSvHWc2eb0130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623511.RALgDG1eFc9iwZGX08fEgmy8tB8sC670TAhJSvHWc2eb0130_provenance.
• NP625493.RAPQ-8Spm9Qlk2yHoKL0L-xHVJE9BRlziKioiDJqcaNLQ130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625493.RAPQ-8Spm9Qlk2yHoKL0L-xHVJE9BRlziKioiDJqcaNLQ130_provenance.
• NP622196.RA0Y5QdNgkWgU9hPfDgt91o9rvpqrPxC-z5g6C3xac8AQ130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622196.RA0Y5QdNgkWgU9hPfDgt91o9rvpqrPxC-z5g6C3xac8AQ130_provenance.
• NP1233084.RAJJOZchW7VAb01kzXngc7dsioze1FESWf6eD-7hgRmvs130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233084.RAJJOZchW7VAb01kzXngc7dsioze1FESWf6eD-7hgRmvs130_provenance.
• NP1233093.RAJ6MbM3kjaWyC6GCXs2X20nO--EHRHVqQ_C2eBp7cKCI130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233093.RAJ6MbM3kjaWyC6GCXs2X20nO--EHRHVqQ_C2eBp7cKCI130_provenance.
• NP1233082.RA8WIil_4mVBluk9LCaSAKrjxeo-tILL4JitYq4GDtMvE130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233082.RA8WIil_4mVBluk9LCaSAKrjxeo-tILL4JitYq4GDtMvE130_provenance.
• NP1233083.RA_ckWd0oIE63L7do8N-doinSmMZEtxLjLdXQrAK1iL28130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233083.RA_ckWd0oIE63L7do8N-doinSmMZEtxLjLdXQrAK1iL28130_provenance.